Immunodeficiency and autoimmunity during biological disease-modifying antirheumatic drug therapy

Biological disease-modifying antirheumatic drugs target specific components of the immune response related to pathogenesis of autoimmune and inflammatory diseases. Introduction of biologic therapies has enabled better disease control than conventional drugs and thus a reduction in comorbidity and mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Czekalska, Anna, Majewski, Dominik, Puszczewicz, Mariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2019
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753594/
https://www.ncbi.nlm.nih.gov/pubmed/31548748
http://dx.doi.org/10.5114/reum.2019.87616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753594/
https://www.ncbi.nlm.nih.gov/pubmed/31548748
http://dx.doi.org/10.5114/reum.2019.87616

Ejemplares similares